32
https://pubmed.ncbi.nlm.nih.gov/38091504
Scientists have identified and characterized a small molecule, “C2,” that binds to Bruton’s Tyrosine Kinase (BTK) outside of the active site, acting as a potential allosteric activator, increasing the catalytic efficiency of BTK and activating BTK XLA mutants.
